Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway. [electronic resource]
Producer: 20160506Description: 850-60 p. digitalISSN:- 1463-1326
- Androstadienes -- pharmacology
- Animals
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Chromones -- pharmacology
- Diabetes Mellitus, Type 2 -- complications
- Enzyme Inhibitors -- pharmacology
- Gene Expression Regulation, Neoplastic -- drug effects
- Glucagon-Like Peptide-1 Receptor -- drug effects
- Humans
- Hypoglycemic Agents -- pharmacology
- Immunohistochemistry
- Liraglutide -- pharmacology
- Male
- Mice
- Mice, Nude
- Morpholines -- pharmacology
- Neoplasm Invasiveness
- Pancreatic Neoplasms -- etiology
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphoinositide-3 Kinase Inhibitors
- Phosphorylation
- Proto-Oncogene Proteins c-akt -- drug effects
- Signal Transduction -- drug effects
- Wortmannin
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.